HOB Biotech Group Corp.,Ltd

Equities

688656

CNE100004C37

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 02/07/2024 BST			5-day change	1st Jan Change
21.86 ^CNY	-2.28%		-7.72%	-37.11%

05-21	Tranche Update on HOB Biotech Group Corp.,Ltd's Equity Buyback Plan announced on March 11, 2024.	CI
05-20	HOB Biotech Group Corp.,Ltd's Equity Buyback announced on March 11, 2024, has closed with 801,314 shares, representing 1.27% for CNY 20 million.	CI

Tranche Update on HOB Biotech Group Corp.,Ltd's Equity Buyback Plan announced on March 11, 2024.

May 21, 2024 at 05:00 pm

From March 8, 2024 to May 20, 2024, the company has repurchased 801,314 shares, representing 1.27% for CNY 20 million. With this, the company has completed the repurchase of 801,314 shares, representing 1.27% for CNY 20 million under the buyback announced on March 11, 2024.

Latest news about HOB Biotech Group Corp.,Ltd

Tranche Update on HOB Biotech Group Corp.,Ltd's Equity Buyback Plan announced on March 11, 2024.	05-21	CI
HOB Biotech Group Corp.,Ltd's Equity Buyback announced on March 11, 2024, has closed with 801,314 shares, representing 1.27% for CNY 20 million.	05-19	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	03-11	CI
HOB Biotech Group Corp.,Ltd authorizes a Buyback Plan.	03-07	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	02-02	CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024.	01-13	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
HOB Biotech Inks Deal With Spain’s Inmunotek to Distribute Allergy Treatment in China	06/09/23	MT
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22	CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange Composite Index	21/01/22	CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange A Share Index	21/01/22	CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2022.	13/01/22	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	20/10/21	CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	18/08/21	CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21/04/21	CI
HOB Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	14/04/21	CI
HOB Biotech : Surges 112% in Shanghai Trading Debut	14/01/21	MT
Hob Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	07/01/21	CI

Chart HOB Biotech Group Corp.,Ltd

Duration

Period

More charts

Company Profile

HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
HOB BIOTECH GROUP CORP.,LTD	-37.11%	189M
ABBOTT LABORATORIES	-7.03%	178B
MEDTRONIC PLC	-6.32%	98.95B
BECTON, DICKINSON AND COMPANY	-6.15%	66.14B
DEXCOM, INC.	-10.62%	44.11B
CENCORA, INC.	+8.34%	43.82B
HOYA CORPORATION	+11.91%	42.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+11.64%	28.92B
TERUMO CORPORATION	+17.68%	24.69B
WEST PHARMACEUTICAL SERVICES, INC.	-8.87%	23.38B

Other Medical Equipment, Supplies & Distribution